Review
Published on 13 Oct 2025
Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb
in Multiple Sclerosis and Neuroimmunology
- 313 views
Review
Published on 13 Oct 2025
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 13 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Oct 2025
in Infectious Diseases: Pathogenesis and Therapy
Systematic Review
Published on 13 Oct 2025
in Autism
Original Research
Published on 13 Oct 2025
in Technical Advances in Plant Science
Case Report
Published on 13 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Oct 2025
in Gender, Sex and Sexualities
Original Research
Published on 13 Oct 2025
in Aging and Public Health
Original Research
Published on 13 Oct 2025
in Healthy Longevity
Conceptual Analysis
Published on 13 Oct 2025
in Machine Learning and Artificial Intelligence
Review
Published on 13 Oct 2025
in Diabetes: Molecular Mechanisms
Original Research
Published on 13 Oct 2025
in Environmental Health and Exposome
Original Research
Published on 13 Oct 2025
in Gut Endocrinology
Systematic Review
Published on 13 Oct 2025
in Occupational Health and Safety
Brief Research Report
Published on 13 Oct 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 13 Oct 2025
in Public Health Policy